Literature DB >> 3003256

Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?

K Felgenhauer, H J Schädlich, M Nekic, R Ackermann.   

Abstract

Specific antibody activities (antibody per weight unit IgG) of serum and CSF against a broad variety of viruses were compared in multiple sclerosis and certain inflammatory diseases of the central nervous system, e.g. neurosyphilis, as well as herpes simplex and zoster encephalitis. No "unspecific" antiviral activities within the CSF compartment were found in the non-MS diseases. The most frequent antibodies locally produced were directed against measles, rubella and zoster antigens. A diagnostic test with these three viruses would give positive results in about 80% of patients with MS. This finding is not as frequent as the oligoclonal pattern of the CSF gamma-globulins but would have a considerably greater diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3003256     DOI: 10.1016/0022-510x(85)90067-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  23 in total

1.  Immunological differentiation between neuroborreliosis and multiple sclerosis.

Authors:  J Heller; G Holzer; K Schimrigk
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Changing patterns of glucose metabolism during the course of subacute sclerosing panencephalitis as measured with 18FDG-positron-emission tomography.

Authors:  M Huber; G Pawlik; S Bamborschke; G R Fink; H Karbe; M Schlenker; H Bewermeyer; W D Heiss
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

3.  No evidence of Borna disease virus-specific antibodies in multiple sclerosis patients in Germany.

Authors:  B Kitze; S Herzog; P Rieckmann; S Poser; J Richt
Journal:  J Neurol       Date:  1996-09       Impact factor: 4.849

4.  Anti-idiotypic antibodies to rubella virus.

Authors:  A Nath; B Slagle; J S Wolinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 5.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

6.  Chronic HIV encephalitis--II. Clinical aspects.

Authors:  S Poser; W Lüer; D Eichenlaub; H D Pohle; T Weber; S Jürgens; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1988-01-04

7.  Local IgG production in aqueous humour in patients with idiopathic uveitis compared with MRI findings.

Authors:  S Koscielny; P Thulliez; E A Cabanis; M T Iba-Zizen; E Dussaix; E Bloch-Michel; C Trichet; L Helleboid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

8.  Cerebrospinal fluid immunoglobulins and virus-specific antibodies in disorders affecting the facial nerve.

Authors:  T Weber; S Jürgens; W Lüer
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

9.  Acute encephalitis with intrathecal synthesis of measles antibodies.

Authors:  H J Schädlich; A Karenberg; M Nekic; K Felgenhauer
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

Review 10.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.